Management of Enteritis Associated With Tricohepatoenteric Syndrome due to <i>SKIV2L</i> Mutation Using the Combination of JAK1/2 Inhibition and Azathioprine.

Talbot, Jonathan; Wiskin, Anthony E; Monaghan, Marie; Goenka, Anu; Rice, Gillian; Roderick, Marion

Management of Enteritis Associated With Tricohepatoenteric Syndrome due to SKIV2L Mutation Using the Combination of JAK1/2 Inhibition and Azathioprine.

Talbot, Jonathan; Wiskin, Anthony E; Monaghan, Marie; Goenka, Anu; Rice, Gillian; Roderick, Marion.

Affiliation

Talbot J; From the Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, UK.
Wiskin AE; Paediatric Gastroentology, Bristol Royal Hospital for Children, UK.
Monaghan M; Cellular and Molecular Medicine, University of Bristol, UK.
Goenka A; From the Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, UK.
Rice G; Cellular and Molecular Medicine, University of Bristol, UK.
Roderick M; Department of genetic Medicine, University of Manchester, UK.

JPGN Rep ; 3(4): e264, 2022 Nov.

Article in En | MEDLINE | ID: mdl-37168478